Although PTEN is regarded as a tumour suppressor, high PTEN expression in general tissues was not indicative of improved survival among BRCA patients (Fig. 1A, Supplementary Fig. 1A & 1B), as determined by our analysis of patient data from the TCGA-BRCA database. The gene discussed is PTEN; the disease is neoplasm.